Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial., Ndiaye, Birahim Pierre, Thienemann Friedrich, Ota Martin, Landry Bernard S., Camara Makhtar, Dièye Siry, Dieye Tandakha Ndiaye, Esmail Hanif, Goliath Rene, Huygen Kris, et al. , Lancet Respir Med, 2015 Mar, Volume 3, Issue 3, p.190-200, (2015)